The Zacks Analyst Blog Highlights Microsoft, Anheuser-Busch InBev, HCA Healthcare, Delta Air Lines and TELUS
For Immediate Release
Chicago, IL – June 30, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corp. MSFT, Anheuser-Busch InBev SA/NV BUD, HCA Healthcare HCA, Delta Air Lines DAL and TELUS TU.
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Microsoft, Anheuser-Busch InBev & HCA Healthcare
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp., Anheuser-Busch InBev SA/NV and HCA Healthcare. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Microsoft shares have outperformed the Zacks Computer - Software industry over the past six months (+40.7% vs. +39.0%) on the back of the company's AI leverage. The company is riding on strong growth from Intelligent Cloud and Productivity and Business Processes. Intelligent Cloud revenues have been driven by growth in Azure and other cloud services.
Productivity and Business Processes revenues continue to increase due to strong adoption of Office 365 Commercial solutions. Continued momentum in the small and medium businesses and frontline worker offerings, as well as gain in revenue per user drove top-line growth.
However, More Personal Computing revenues decreased due to weak Windows and Devices businesses. Steady performance in Talent Solutions aided LinkedIn revenues. Also, declining gaming revenues has been a headwind. Increasing spend on Azure enhancements amid stiff competition in the cloud space remains a concern.
(You can read the full research report on Microsoft here >>>)
Shares of Anheuser-Busch InBev have outperformed the Zacks Beverages - Alcohol industry over the past year (+4.6% vs. +2.5%). The company has been benefiting from continued business momentum, which resulted in top and bottom-line growth in first-quarter 2023. Further, the company’s relentless execution, investment in brands and accelerated digital transformation aided performance.
The top line benefited from strong consumer demand for its portfolio, consistent execution of its strategy and strength of the beer category globally. The expansion of the Beyond Beer portfolio, and investments in B2B platforms, e-commerce and digital marketing bode well. Backed by the continued business momentum, the company outlined its view for 2023.
However, shares of AB InBev lagged the industry in the past three months on lower-than-expected earnings in the first quarter. AB InBev’s gross and EBIT margin declined in the first-quarter, driven by higher cost of sales and SG&A expense.
(You can read the full research report on Anheuser-Busch here >>>)
HCA Healthcare shares have outperformed the Zacks Medical - Hospital industry over the past year (+79.9% vs. +66.5%). The company’s revenues remain on an uptick on the back of a surge in admissions, outpatient surgeries and other procedures. Multiple buyouts aided it in increasing patient volumes, enabled network expansion, added hospitals to its portfolio and boosted business scale.
HCA Healthcare has been gaining from its telemedicine business line. HCA Healthcare resorts to prudent capital deployment via buybacks and dividends. As of Mar 31, 2023, it had $3.7 billion left under its buyback authorization. A solid business outlook added to the positives.
However, the company's escalating operating expenses have been weighing on the margins. A high debt level induces rise in interest expenses. As such, the stock warrants a cautious stance.
(You can read the full research report on HCA Healthcare here >>>)
Other noteworthy reports we are featuring today include Delta Air Lines and TELUS.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
TELUS Corporation (TU) : Free Stock Analysis Report
Microsoft Corporation (MSFT) : Free Stock Analysis Report
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
Anheuser-Busch InBev SA/NV (BUD) : Free Stock Analysis Report
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
